List of works - Sara Heebøll

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

scientific article

Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.

scientific article

Effect of resveratrol on experimental non-alcoholic steatohepatitis.

scientific article published on 23 March 2015

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

scientific article

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

scientific article (publication date: 15 February 2009)

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.

scientific article

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

scientific article published on 05 September 2019

Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

scientific article published on April 2016

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer

scientific article

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

scientific article published in January 2018

Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.

scientific article published on 11 June 2013

Prostate cancer: to scan or not to scan for lymph node involvement?

scientific article published on 01 January 2007

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

scientific article published on 18 November 2010

Snail1 is over-expressed in prostate cancer

scientific article

Urea cycle dysregulation in non-alcoholic fatty liver disease

scientific article published on 05 July 2018

[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]

scientific article published on 01 February 2012

[Treatment of non-alcoholic fatty liver disease] ⬇️

scientific article published on 01 July 2018

List of works by Sara Heebøll

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.

Effect of resveratrol on experimental non-alcoholic steatohepatitis.

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.

Prostate cancer: to scan or not to scan for lymph node involvement?

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

Snail1 is over-expressed in prostate cancer

Urea cycle dysregulation in non-alcoholic fatty liver disease

[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]

[Treatment of non-alcoholic fatty liver disease] ⬇️